Created at	Source	Raw Value	Validated value
March 31, 2021, 4:03 p.m.	oms	• To assess the safety and tolerability of Ampligen administered intranasally in a dosing schedule for 13 days (7 doses) in healthysubjects.• To characterize the mucosal immune response following Ampligen administration over time.	• To assess the safety and tolerability of Ampligen administered intranasally in a dosing schedule for 13 days (7 doses) in healthysubjects.• To characterize the mucosal immune response following Ampligen administration over time.